OOIR: Observatory of International Research

Papers

(The H4-Index of Trends in Cancer is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Subscription & copyright page	274
FBXW10: a male-biased E3 ligase in liver cancer	264
Engineering growth factor ligands and receptors for therapeutic innovation	250
Targeting solid tumor antigens with chimeric receptors: cancer biology meets synthetic immunology	242
Cancer evolution: from Darwin to the Extended Evolutionary Synthesis	216
Revumenib: a new era in acute leukemia treatment	211
Advancements in organoid models emulating metastatic niches	210
Clinical perspective and treatment of immune-related colitis after cancer immunotherapy	201
Spliced to kill: RNA mis-splicing derived cancer neoantigens	199
Platelets: tailoring metastasis treatment	189
Tumor-resident microbes: the new kids on the microenvironment block	185
Navigating life as an early career researcher	177
Subscription & copyright page	167
Subscription and copyright page	165
Advisory Board and Contents	159
Leveraging circulating microbial DNA for early cancer detection	157
Onco-condensates: formation, multi-component organization, and biological functions	152
Accessing the vasculature in cancer: revising an old hallmark	144
Engine shutdown: migrastatic strategies and prevention of metastases	143
Subscription & copyright page	131
Molecular insights into SMARCA2 degradation in SMARCA4-mutant lung cancers	115
Nonrepair functions of DNA mismatch repair proteins: new avenues for precision oncology	115
From prediction to precision: how immunopeptidomics advances neoantigen discovery	108
Gut microbiota – a double-edged sword in cancer immunotherapy	107
Advancements in combining targeted therapy and immunotherapy for colorectal cancer	105

The evolving landscape of brain metastasis: volume II	103
Oncogenic competence: balancing mutations, cellular state, and microenvironment	102
cGAS–STING and the deadly CIN: how chronic inflammation represents a therapeutic vulnerability in chromosomally unstable cancers	101
Diet, nutrient supply, and tumor immune responses	99
Chromatin as an old and new anticancer target	94
Regulation of metastatic organotropism	92
Recent developments in myeloid immune modulation in cancer therapy	86
GOT2 consider the tumor microenvironment	83
Targeting the Hippo pathway in cancer: kidney toxicity as a class effect of TEAD inhibitors?	80
FGFR rearrangements: oncogenic drivers and therapeutic targets	79
Benefits and opportunities of the transgenic Oncopig cancer model	77
Crosstalk of T cells within the ovarian cancer microenvironment	76
The gut–liver axis: host microbiota interactions shape hepatocarcinogenesis	74
Circulating tumor DNA in biliary tract cancers: challenges, opportunities, and clinical readiness	73
Cell death, therapeutics, and the immune response in cancer	71
Neural hijacking in cancer metabolism: from nutrients to organelles	70
Advisory Board and Contents	69
Cancer immunotherapeutic challenges from autophagy-immune checkpoint reciprocal regulation	66
Subscription & copyright page	66
Insights on ErbB glycosylation – contributions to precision oncology	65
Palmitate paves the way to lung metastasis	65
Genetic immune escape in cancer: timing and implications for treatment	63
Scaling data toward pan-cancer foundation models	63
The emerging field of oncolytic virus-based cancer immunotherapy	61
Toward mutational epidemiology: using mutational signatures of environmental exposures to assess cancer risk	61
Organellar pH as an emerging vulnerability to exploit in cancer	61
Planning for cancer: building accessible and high-quality survivorship care for all	61
Inflammation: the incubator of the tumor microenvironment	60
Clinical and translational relevance of intratumor heterogeneity	59
Subscription & copyright page	57
Advisory Board and Contents	56
Advisory Board and Contents	56
Advisory Board and Contents	56